Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
10.97
+0.05 (0.46%)
At close: Aug 14, 2026, 4:00 PM EDT
10.77
-0.20 (-1.80%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Immix Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 225.49 | 93.93 | 17.68 | 17.51 | 13.44 | 17.64 |
Short-Term Investments | 6.62 | 6.48 | - | - | - | - |
Cash & Short-Term Investments | 232.11 | 100.41 | 17.68 | 17.51 | 13.44 | 17.64 |
Cash Growth | 1894.40% | 467.86% | 0.98% | 30.31% | -23.85% | 4411.66% |
Other Receivables | - | - | 1.97 | 1.17 | 0.26 | 0.03 |
Receivables | - | - | 1.97 | 1.17 | 0.26 | 0.03 |
Prepaid Expenses | 1.4 | 0.68 | 0.51 | 1.06 | 1.13 | 0.52 |
Other Current Assets | 0.28 | 0.15 | 0.03 | 0.04 | 0.08 | - |
Total Current Assets | 233.79 | 101.24 | 20.2 | 19.79 | 14.9 | 18.19 |
Property, Plant & Equipment | 3.25 | 3.49 | 2.73 | 0.05 | 0 | 0.01 |
Long-Term Deferred Charges | - | 0.09 | - | 0.09 | 0.01 | - |
Other Long-Term Assets | 0.02 | 0.02 | 0.02 | - | - | - |
Total Assets | 239.11 | 104.84 | 22.95 | 19.93 | 14.91 | 18.19 |
Accounts Payable | 5.28 | 5.44 | 5.39 | 1.43 | 0.14 | 0.14 |
Accrued Expenses | 3.91 | 4.53 | 3.23 | 2.29 | 1.13 | 0.01 |
Short-Term Debt | - | - | - | - | - | 0.05 |
Current Portion of Leases | 0.11 | 0.14 | 0.07 | - | - | - |
Total Current Liabilities | 9.3 | 10.11 | 8.69 | 3.72 | 1.27 | 0.2 |
Long-Term Leases | 0.89 | 0.93 | 1.01 | - | - | - |
Other Long-Term Liabilities | - | - | - | - | 0.48 | - |
Total Liabilities | 10.19 | 11.04 | 9.7 | 3.72 | 1.75 | 0.2 |
Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 355 | 198.29 | 88.37 | 69.78 | 51.16 | 47.62 |
Retained Earnings | -126.11 | -104.46 | -75.02 | -53.41 | -37.99 | -29.76 |
Treasury Stock | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | - |
Comprehensive Income & Other | 0.12 | 0.06 | -0 | 0.13 | 0.09 | 0.13 |
Total Common Equity | 228.92 | 93.8 | 13.25 | 16.41 | 13.16 | 17.99 |
Minority Interest | - | - | - | -0.2 | - | - |
Shareholders' Equity | 228.92 | 93.8 | 13.25 | 16.2 | 13.16 | 17.99 |
Total Liabilities & Equity | 239.11 | 104.84 | 22.95 | 19.93 | 14.91 | 18.19 |
Total Debt | 1 | 1.07 | 1.07 | - | - | 0.05 |
Net Cash (Debt) | 231.11 | 99.34 | 16.61 | 17.51 | 13.44 | 17.59 |
Net Cash Growth | 2081.24% | 498.15% | -5.16% | 30.31% | -23.63% | - |
Net Cash Per Share | 4.83 | 3.01 | 0.59 | 1.01 | 0.97 | 4.79 |
Filing Date Shares Outstanding | 71.54 | 52.96 | 27.72 | 26.4 | 13.9 | 13.86 |
Total Common Shares Outstanding | 71.54 | 52.95 | 27.54 | 19.92 | 13.89 | 13.23 |
Working Capital | 224.49 | 91.13 | 11.51 | 16.07 | 13.62 | 17.98 |
Book Value Per Share | 3.20 | 1.77 | 0.48 | 0.82 | 0.95 | 1.36 |
Tangible Book Value | 228.92 | 93.8 | 13.25 | 16.41 | 13.16 | 17.99 |
Tangible Book Value Per Share | 3.20 | 1.77 | 0.48 | 0.82 | 0.95 | 1.36 |
Machinery | 1.59 | 1.57 | 0.85 | 0.06 | - | - |
Construction In Progress | - | - | 0.94 | - | - | - |
Leasehold Improvements | 1.24 | 1.24 | - | - | - | - |